Economic assessment of a new model of care to support patients with cancer experiencing cancer- and treatment-related toxicities

Shih, Sophy TF, Mellerick, Angela, Akers, Georgina, Whitfield, Kathryn and Moodie, Marj 2020, Economic assessment of a new model of care to support patients with cancer experiencing cancer- and treatment-related toxicities, JCO oncology practice, vol. 16, no. 9, pp. E884-E892, doi: 10.1200/JOP.19.00702.

Attached Files
Name Description MIMEType Size Downloads

Title Economic assessment of a new model of care to support patients with cancer experiencing cancer- and treatment-related toxicities
Author(s) Shih, Sophy TFORCID iD for Shih, Sophy TF orcid.org/0000-0003-0049-2888
Mellerick, Angela
Akers, Georgina
Whitfield, Kathryn
Moodie, MarjORCID iD for Moodie, Marj orcid.org/0000-0001-6890-5250
Journal name JCO oncology practice
Volume number 16
Issue number 9
Start page E884
End page E892
Total pages 9
Publisher American Society of Clinical Oncology
Place of publication Alexandria, Va.
Publication date 2020-09-01
ISSN 2688-1527
2688-1535
Keyword(s) Science & Technology
Life Sciences & Biomedicine
Oncology
Summary PURPOSE:The aim of this economic assessment was to evaluate the impact of a new nurse-led model of care, the Symptom and Urgent Review Clinic (SURC), for patients with cancer experiencing disease- or treatment-related symptoms. METHODS: An economic assessment was undertaken to estimate costs of the SURC from the service funder perspective and to compare the cost with cost offsets stemming from the implementation of the SURC. The cost offsets focused on the changes in emergency department (ED) presentations and inpatient admissions during a comparable 6-month period before and after the SURC implementation. Costs were analyzed in 2018 Australian dollars, and return on investment was calculated by comparing the cost offsets in the ED and inpatient units with the cost of the SURC. RESULTS: After the implementation of the SURC, patients were less likely to present to the ED (7.2% v 8.5%; P = .01), and patients who did present to the ED were more likely to be admitted to inpatient units (78% v 71%; P = .03) for additional treatment. The post-SURC period had a net cost savings of $37,090 compared with the pre-SURC period. From the service funder perspective, the SURC achieved an investment return of $1.73 for every dollar invested in the new service. CONCLUSION: Our study establishes the economic credentials of a new care model using empirical linked hospital service data. The SURC presents a new cancer care service for policy consideration from an economic standpoint. It demonstrates an efficient approach to hospital resource allocation to deliver quality cancer care.
Language eng
DOI 10.1200/JOP.19.00702
Indigenous content off
HERDC Research category C1 Refereed article in a scholarly journal
Persistent URL http://hdl.handle.net/10536/DRO/DU:30136848

Document type: Journal Article
Collections: Faculty of Health
Population Health
Connect to link resolver
 
Unless expressly stated otherwise, the copyright for items in DRO is owned by the author, with all rights reserved.

Versions
Version Filter Type
Citation counts: TR Web of Science Citation Count  Cited 3 times in TR Web of Science
Scopus Citation Count Cited 1 times in Scopus
Google Scholar Search Google Scholar
Access Statistics: 60 Abstract Views, 1 File Downloads  -  Detailed Statistics
Created: Mon, 11 May 2020, 13:54:35 EST

Every reasonable effort has been made to ensure that permission has been obtained for items included in DRO. If you believe that your rights have been infringed by this repository, please contact drosupport@deakin.edu.au.